Compare BGH & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGH | LFMD |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.7M | 218.1M |
| IPO Year | 2011 | 2012 |
| Metric | BGH | LFMD |
|---|---|---|
| Price | $12.87 | $2.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $8.13 |
| AVG Volume (30 Days) | 95.6K | ★ 823.6K |
| Earning Date | 01-01-0001 | 11-16-2026 |
| Dividend Yield | ★ 10.06% | N/A |
| EPS Growth | N/A | ★ 141.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,468,578.00 |
| Revenue This Year | N/A | $7.00 |
| Revenue Next Year | N/A | $18.09 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $12.90 | $2.60 |
| 52 Week High | $15.45 | $6.99 |
| Indicator | BGH | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 20.58 | 30.81 |
| Support Level | N/A | $2.66 |
| Resistance Level | $14.35 | $3.46 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 6.95 | 0.00 |
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation. The Fund seeks capital appreciation as a secondary investment objective when consistent with its primary investment objective. Under normal market conditions, the Fund will invest at least 80% of its Managed Assets in bonds, loans and other income-producing instruments that are, at the time of purchase, rated below investment grade.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.